ISSN 1671-5411 CN 11-5329/R

Dear Colleagues,

Journal of Geriatric Cardiology (J Geriatr Cardiol, JGC) will launch a new website and adopt ScholarOne ManuscriptsTM system to manage the submission and peer review process from November 1, 2020. To review and check the status of your manuscripts submitted before November 2020, please visit...

more

Juan WANG, Guo-Juan TAN, Li-Na HAN, Yong-Yi BAI, Miao HE, Hong-Bin LIU. Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol 2017; 14(2): 135-150. doi: 10.11909/j.issn.1671-5411.2017.02.008
Citation: Juan WANG, Guo-Juan TAN, Li-Na HAN, Yong-Yi BAI, Miao HE, Hong-Bin LIU. Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol 2017; 14(2): 135-150. doi: 10.11909/j.issn.1671-5411.2017.02.008

Novel biomarkers for cardiovascular risk prediction

doi: 10.11909/j.issn.1671-5411.2017.02.008
Funds:

This study was supported by Central Health Care Fund (W2015ZD02).

  • Received Date: 2016-12-09
  • Rev Recd Date: 2017-02-14
  • Publish Date: 2017-02-28
  • Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. The primary prevention of CVD is dependent upon the ability to identify high-risk individuals long before the development of overt events. This highlights the need for accurate risk stratification. An increasing number of novel biomarkers have been identified to predict cardiovascular events. Biomarkers play a critical role in the definition, prognostication, and decision-making regarding the management of cardiovascular events. This review focuses on a variety of promising biomarkers that provide diagnostic and prognostic information. The myocardial tissue-specific biomarker cardiac troponin, high- sensitivity assays for cardiac troponin, and heart-type fatty acid binding proteinall help diagnose myocardial infarction (MI) in the early hours following symptoms. Inflammatory markers such as growth differentiation factor-15, high-sensitivity C-reactive protein, fibrinogen, and uric acid predict MI and death. Pregnancy-associated plasma protein A, myeloperoxidase, and matrix metalloproteinases predict the risk of acute coronary syndrome. Lipoprotein-associated phospholipase A2 and secretory phospholipase A2 predict incident and recurrent cardiovascular events. Finally, elevated natriuretic peptides, ST2, endothelin-1, mid-regional-pro-adrenomedullin, copeptin, and galectin-3 have all been well vali?dated to predict death and heart failure following a MI and provide risk stratification information for heart failure. Rapidly developing new areas, such as assessment of micro-RNA, are also explored. All the biomarkers reflect different aspects of the development of atherosclerosis.
  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1393) PDF downloads(1250) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return